Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients
NCT05325970
Dental Diseases, Head and Neck Cancer
Farmington, Connecticut, United States
View Trial DetailsNCT Number: NCT02057510
The purpose of this study is to measure the two-year rate of tooth loss in patients who have received external beam radiation therapy with curative intent for head and neck cancer. The study will also evaluate the sequelae of radiation therapy and oral complications that may occur as a result to receiving radiation therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University of Connecticut Health Center - School of Dental Medicine, Farmington, Connecticut, United States
This is a prospective cohort study to document dental and other oral outcomes in patients who receive external beam radiation therapy with curative intent, as part of clinical care for a head and neck cancer. Five hundred and seventy-five participants will be enrolled. All study participants will receive a baseline oral examination prior to the start of radiation therapy. Follow-up examinations and data collection will be conducted at six-month intervals up to 2 years after the start of radiation therapy. The primary outcome will be the two-year rate of tooth loss. Secondary outcomes will include measures of dental caries, periodontal health, salivary flow, and exposed bone/osteoradionecrosis.
The proposed research will provide more information to inform the community about the sequelae of Radiation Therapy (RT) in head and neck cancer patients, to refine current guidelines and to design future studies on the dental management of these patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
OR
Exclusion criteria
Time frame: Two Years
The primary outcome measure is the two-year rate of tooth loss in patients who have received at least one session of external beam radiation therapy with curative intent for head and neck cancer.
"Tooth loss" will be defined as a dental extraction that has been performed or recommended. Since dental extractions are often avoided in this population because of the increased risk of osteoradionecrosis (ORN), tooth loss will also include teeth having a dental procedure to avoid extraction of a tooth that would otherwise have been extracted if the individual had not received RT and teeth recommended for extraction that have not been treated. The following categories will constitute teeth that would otherwise be recommended for extraction:
Time frame: Two Years
Two year incidence of exposed intraoral bone, suggestive of ORN. This will be defined as exposed maxillary or mandibular bone with an avascular appearance in a quadrant that has received RT
Time frame: Within 14 days following procedure
Incidence of post-extraction complications
Time frame: Baseline, 24 months
Two year change in DMFS - Decayed, Missing or Filled Surfaces Index
Time frame: Baseline, 24 months
Two year change in periodontal measures
Time frame: Baseline, 18 months
18 month changes in stimulated whole salivary flow rates
Time frame: Baseline, 24 months
Two year change in mouth opening in mm
Time frame: Baseline, 24 months
Two year use of fluoride to prevent new caries
Time frame: Baseline, 24 months
Two year chronic oral mucositis incidence
Time frame: Baseline, 24 months
Two year change in radiation therapy-specific quality of life measures
Time frame: Baseline, 24 months
Two year change in pain scores as measured with the University of California at San Francisco (UCSF) oral cancer pain scale
Wake Forest University Health Sciences
Other
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients
Acronym: ORARAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05325970
Dental Diseases, Head and Neck Cancer
Farmington, Connecticut, United States
View Trial DetailsNCT04717765
Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Diseases
Santiago de Compostela, LA Coruña, Spain
View Trial DetailsNCT06428994
Fibula Flap, Head and Neck Cancer
Taoyuan, Taiwan
View Trial DetailsNCT04608773
Head and Neck Cancer, Head and Neck Neoplasms
Pittsburgh, Pennsylvania, United States
View Trial Details